Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III/IV trial of live attenuated varicella vaccine in children aged 1-12 years
ChiCTR1900020665Phase 4Recruiting
- Sponsor
- Guizhou Center for Disease Control and Prevention
- Start
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of varicella vaccine live in chickenpox (2 arms), sponsored by Guizhou Center for Disease Control and Prevention. Primary endpoint: Positive conversion rate of varicella virus antibody. Started Jan 2019; status: recruiting.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR1900020665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020665.